NCT00302991已完成不适用
Quality of Life and Adverse Effects in Epilepsy Patients According to Treatment Group (EPIKA)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- UCB Pharma
- 入组人数
- 180
研究概览
简要总结
Observational, multicentre, epidemiological study to determine the HRQOL of patients with epilepsy according to treatment sub-group and to validate the Spanish version of the Adverse Events Profile, produced by G. Baker et al. Three treatment groups will be examined: patients receiving only a new anti-epilepsy drug (AED), patients receiving a "classic" AED; patients receiving combination therapy.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Epileptic adult patients treated at a stable dose with one or more AEDs for ≥ 3 months
排除标准
- •Symptomatic epilepsy due to malignant brain tumour or progressive brain disease.
- •Confirmed diagnosis of a concomitant chronic disease
研究者
相似试验
已完成
不适用
Comparison of Quality of Life and Changes Experienced by Patients After Epilepsy SurgeryEpilepsyNCT06035965University Hospital, Toulouse151
Unknown
不适用
Mainz Epilepsy RegistryDissociative SeizuresEpilepsyStatus EpilepticusNCT05267405Johannes Gutenberg University Mainz700
终止
不适用
Embrace and Quality of LifeEpilepsy, Tonic-ClonicNCT03831802Centre Hospitalier Universitaire Vaudois26
已完成
不适用
Enhancing Medical Compliance and Health-related Quality of Life of Patients With EpilepsyEpilepsyNCT02547389NMP Medical Research Institute144
已完成
不适用
Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For EpilepsyEpilepsyNCT00264680GlaxoSmithKline333